收藏 分享(赏)

ETC-206-SDS-MedChemExpress.pdf

上传人:MedChemExpress 文档编号:407976 上传时间:2019-06-11 格式:PDF 页数:5 大小:118.88KB
下载 相关 举报
ETC-206-SDS-MedChemExpress.pdf_第1页
第1页 / 共5页
ETC-206-SDS-MedChemExpress.pdf_第2页
第2页 / 共5页
ETC-206-SDS-MedChemExpress.pdf_第3页
第3页 / 共5页
ETC-206-SDS-MedChemExpress.pdf_第4页
第4页 / 共5页
ETC-206-SDS-MedChemExpress.pdf_第5页
第5页 / 共5页
亲,该文档总共5页,全部预览完了,如果喜欢就下载吧!
资源描述

1、ended storage temperature:Powder-20C 3 years4C 2 yearsIn solvent-80C 6 months-20C 1 monthShipping at room temperature if less than 2 weeks.7.3 Specific end use(s)No data available.8. EXPOSURE CONTROLS/PERSONAL PROTECTION8.1 Control parametersComponents with workplace control parametersThis product c

2、ontains no substances with occupational exposure limit values.8.2 Exposure controlsEngineering controlsEnsure adequate ventilation. Provide accessible safety shower and eye wash station.Personal protective equipmentEye protection Safety goggles with side-shields.Hand protection Protective gloves.Ski

3、n and body protection Impervious clothing.Respiratory protection Suitable respirator.Environmental exposure controlsKeep the product away from drains, water courses or the soil. Cleanspillages in a safe way as soon as possible.9. PHYSICAL AND CHEMICAL PROPERTIES9.1 Information on basic physical and

4、chemical propertiesAppearance White to light yellow (Solid)Odor No data availableOdor threshold No data availablepH No data availableMelting/freezing point No data availableBoiling point/range No data availableFlash point No data availableEvaporation rate No data availableFlammability (solid, gas) N

5、o data availableUpper/lower flammability or explosive limitsNo data availableVapor pressure No data availableVapor density No data availableRelative density No data availableWater Solubility No data availablePage 3 of 6 www.MedChemEPartition coefficient No data availableAuto-ignition temperature No

6、data availableDecomposition temperature No data availableViscosity No data availableExplosive properties No data availableOxidizing properties No data available9.2 Other safety informationNo data available.10. STABILITY AND REACTIVITY10.1 ReactivityNo data available.10.2 Chemical stabilityStable und

7、er recommended storage conditions.10.3 Possibility of hazardous reactionsNo data available.10.4 Conditions to avoidNo data available.10.5 Incompatible materialsStrong acids/alkalis, strong oxidising/reducing agents.10.6 Hazardous decomposition productsUnder fire conditions, may decompose and emit to

8、xic fumes.Other decomposition products - no data available.11.TOXICOLOGICAL INFORMATION11.1 Information on toxicological effectsAcute toxicityClassified based on available data. For more details, see section 2Skin corrosion/irritationClassified based on available data. For more details, see section

9、2Serious eye damage/irritationClassified based on available data. For more details, see section 2Respiratory or skin sensitizationClassified based on available data. For more details, see section 2Germ cell mutagenicityClassified based on available data. For more details, see section 2Carcinogenicit

10、yIARC: No component of this product present at a level equal to or greater than 0.1% is identified as probable, possible orconfirmed human carcinogen by IARC.ACGIH: No component of this product present at a level equal to or greater than 0.1% is identified as a potential or confirmedcarcinogen by AC

11、GIH.NTP: No component of this product present at a level equal to or greater than 0.1% is identified as a anticipated or confirmedcarcinogen by NTP.OSHA: No component of this product present at a level equal to or greater than 0.1% is identified as a potential or confirmedcarcinogen by OSHA.Reproduc

12、tive toxicityClassified based on available data. For more details, see section 2Page 4 of 6 www.MedChemESpecific target organ toxicity - single exposureClassified based on available data. For more details, see section 2Specific target organ toxicity - repeated exposureClassified based on available d

13、ata. For more details, see section 2Aspiration hazardClassified based on available data. For more details, see section 212. ECOLOGICAL INFORMATION12.1 ToxicityNo data available.12.2 Persistence and degradabilityNo data available.12.3 Bioaccumlative potentialNo data available.12.4 Mobility in soilNo

14、data available.12.5 Results of PBT and vPvB assessmentPBT/vPvB assessment unavailable as chemical safety assessment not required or not conducted.12.6 Other adverse effectsNo data available.13. DISPOSAL CONSIDERATIONS13.1 Waste treatment methodsProductDispose substance in accordance with prevailing

15、country, federal, state and local regulations.Contaminated packagingConduct recycling or disposal in accordance with prevailing country, federal, state and local regulations.14. TRANSPORT INFORMATIONDOT (US)This substance is considered to be non-hazardous for transport.IMDGThis substance is consider

16、ed to be non-hazardous for transport.IATAThis substance is considered to be non-hazardous for transport.15. REGULATORY INFORMATIONSARA 302 Components:No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302.SARA 313 Components:This material does not cont

17、ain any chemical components with known CAS numbers that exceed the threshold (De Minimis)reporting levels established by SARA Title III, Section 313.SARA 311/312 Hazards:No SARA Hazards.Massachusetts Right To Know Components:No components are subject to the Massachusetts Right to Know Act.Pennsylvan

18、ia Right To Know Components:Page 5 of 6 www.MedChemENo components are subject to the Pennsylvania Right to Know Act.New Jersey Right To Know Components:No components are subject to the New Jersey Right to Know Act.California Prop. 65 Components:This product does not contain any chemicals known to St

19、ate of California to cause cancer, birth defects, or anyother reproductiveharm.16. OTHER INFORMATIONCopyright 2018 MedChemExpress. The above information is correct to the best of our present knowledge but does not purport tobe all inclusive and should be used only as a guide. The product is for rese

20、arch use only and for experienced personnel. It mustonly be handled by suitably qualified experienced scientists in appropriately equipped and authorized facilities. The burden of safeuse of this material rests entirely with the user. MedChemExpress disclaims all liability for any damage resulting f

21、rom handling orfrom contact with this product.Caution: Product has not been fully validated for medical applications. For research use only.Tel: 609-228-6898 Fax: 609-228-5909 E-mail: techMedChemEAddress: 1 Deer Park Dr, Suite Q, Monmouth Junction, NJ 08852, USAPage 6 of 6 www.MedChemE式创新与全球瓶颈技术和先导产

22、品的研发,德国以工业4.0集成系统为抓手,确立全球数字化工业生产模式和标准,英国突破生物和新材料领域核心技术,韩国调整成长动力产业并培育新增长点。总体来看,2016年全球新兴产业规模总体平稳,细分市场分化,技术创新由通用共性技术泓域咨询MACRO/ 无纺设备项目投资备案报告向细分领域聚焦,扶持战略政策更加精准。展望2017年,全球新兴产业中的人工智能等产品将集中发力,全球生产网络趋于稳定,内部融合发展将大力提升价值链延伸能力。2、项目建成投产后,可以大幅度提高企业的经济效益,为公司进一步发展创造条件;更为重要的是,项目承办单位在多年的生产服务承包中,积累了大量的生产经验和管理经验,自主研发的项

23、目产品技术含量高、性能优良、节能环境保护,在整个相关行业中市场潜力巨大。今后一个时期,我国长期积累形成的风险有可能会集中释放,进入风险易发高发期。本文对金融、房地产、政府债务、产业转型、人口老龄化、社会分化、外部冲击等领域可能出现的风险进行了深入分析。这些领域风险点多,影响面广,且相互叠加,传导机制复杂,如果应对不当,有可能对我国经济社会发展形成较大影响。为增强防范化解风险的针对性,本文尝试用德尔菲法,对各领域风险的交互影响程度和发生概率进行评估。评估结果表明,影响力较大同时也是发生概率较高的前四个风险领域是金融风险、房地产风险、政府债务风险、企业债务风险。我国防范化解风险既有多方面优势,也面

24、临诸多挑战。我们要着力防范化解重点领域风险,主动转方式、调结构、换动力、去杠杆、防泡沫,守住不发生系统性风险的底线。二、必要性分析曄曄项目的建设符合xxx国民经济和社会发展第十三个五年规划纲要。今后一个时期,我国长期积累形成的风险有可能会集中释放,进入风险易发高发期。本文对金融、房地产、政府债务、产业转型、人口老龄化、社会分化、外部冲击等领域可能出现的风险进行了深入分析。这些领域风险点多,影响面广,且相互叠加,传导机制复杂,如果应对不当,有可能对我国经济社会发展形成较大影响。为增强防范化解风险的针对性,本泓域咨询MACRO/ 无线以太网设备HSE项目投资备案报告文尝试用德尔菲法,对各领域风险的

25、交互影响程度和发生概率进行评估。评估结果表明,影响力较大同时也是发生概率较高的前四个风险领域是金融风险、房地产风险、政府债务风险、企业债务风险。我国防范化解风险既有多方面优势,也面临诸多挑战。我们要着力防范化解重点领域风险,主动转方式、调结构、换动力、去杠杆、防泡沫,守住不发生系统性风险的底线。二、必要性分析1、中国特色社会主义进入新时代,中华民族迎来了从站起来、富起来到强起来的伟大飞跃。曾以两位数的增幅高速增长的中国经济,在经历连续十几个季度的增速放缓后,于2013年降到8%以内。世界第二大经济体的发展进入新常态。2、快新型工业化进程的关键时期,也是振兴我市制造、推进工业绿色转型的关键时期。

26、我市工业经济发展的内外部环境发生深刻变化,面临着新的机遇和挑战。从国际看:“十三五”国际经济进入金融危机以来的深度调整,新一轮科技革命和产业变革历史性交汇,西方发达国家实施工业4.0和“再工业化”战略,积极抢占未来科技和产业发展制高点,一些发展中国家也在加快谋划和布局,积极参与全球产业再分工,承接产业及资本转移,拓展国际市场空间。新一轮技术革命正在快速兴起,信息网络、生物、可再生能源等新技术正在酝酿新的突破,国际科技创新和产业竞争更趋激烈。从国内看:我国进入全面改革新时代,国家供给侧结构性改革中 Inhibitors, Agonists, Screening Librarieswww.MedC

27、hemESafety Data SheetRevision Date:Oct.-11-2018Print Date: Oct.-11-20181. PRODUCT AND COMPANY IDENTIFICATION1.1 Product identifierProduct name : Chitosan oligosaccharide (COS)Catalog No. : HY-112108CAS No. : 148411-57-81.2 Relevant identified uses of the substance or mixture and uses advised against

28、Identified uses : Laboratory chemicals, manufacture of substances.1.3 Details of the supplier of the safety data sheetCompany: MedChemExpress USATel: 609-228-6898Fax: 609-228-5909E-mail: 1.4 Emergency telephone numberEmergency Phone #: 609-228-68982. HAZARDS IDENTIFICATION2.1 Classification of the s

29、ubstance or mixtureNot a hazardous substance or mixture.2.2 GHS Label elements, including precautionary statementsNot a hazardous substance or mixture.2.3 Other hazardsNone.3. COMPOSITION/INFORMATION ON INGREDIENTS3.1 SubstancesSynonyms: NoneFormula: N/AMolecular Weight: N/ACAS No. : 148411-57-84. F

30、IRST AID MEASURES4.1 Description of first aid measuresEye contactRemove any contact lenses, locate eye-wash station, and flush eyes immediately with large amounts of water. Separate eyelidswith fingers to ensure adequate flushing. Promptly call a physician.Skin contactRinse skin thoroughly with larg

31、e amounts of water. Remove contaminated clothing and shoes and call a physician.Page 1 of 5 www.MedChemEInhalationImmediately relocate self or casualty to fresh air. If breathing is difficult, give cardiopulmonary resuscitation (CPR). Avoid mouth-to-mouth resuscitation.IngestionWash out mouth with water; Do NOT induce vomiting; c

展开阅读全文
相关资源
相关搜索

当前位置:首页 > 研究报告 > 可研报告

本站链接:文库   一言   我酷   合作


客服QQ:2549714901微博号:文库网官方知乎号:文库网

经营许可证编号: 粤ICP备2021046453号世界地图

文库网官网©版权所有2025营业执照举报